Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ArQule to cut liver cancer drug dose on safety concerns
ArQule to cut liver cancer drug dose on safety concerns
ArQule to cut liver cancer drug dose on safety concerns
Submitted by
admin
on September 3, 2013 - 4:20pm
Source:
Reuters
News Tags:
Arqule
liver cancer
tivantinib
Headline:
ArQule to cut liver cancer drug dose on safety concerns
Do Not Allow Advertisers to Use My Personal information
